Janssen Search
Search results
Alexander Grunewald
Alexander Grunewald enables Janssen Healthcare Innovation’s (JHI) growth by identifying, valuing, and championing new business opportunities. Alexander builds strong external relationships with the healthcare innovation and investment communities in areas ...
Fighting Infectious Disease in China
Article Type: Infectious Diseases & Vaccines Tackling Infectious Diseases in China For several years Janssen has partnered with Tsinghua University in Beijing, China to host a Public Health Day that featured academia, leading government officials and ...
Rae Ann Cook
RAE ANN COOK GLOBAL HEAD, OPERATIONS WORLD WITHOUT DISEASE ACCELERATOR As Global Head of Operations, World Without Disease Accelerator (WWDA), Rae Ann has overall strategy realization and operational responsibility for the WWDA and the Lung Cancer ...
Neuropsychiatric Disorders: Expanding our focus to include the full range of psychosis spectrum disorders and mood dysregulation
Neuropsychiatric Disorders: Expanding our focus to include the full range of psychosis spectrum disorders and mood dysregulation Janssen's heritage in neuroscience began more than 60 years ago, when our namesake, Dr. Paul Janssen, developed a drug ...
First 1000 Days QuickFire Challenge
First 1000 Days QuickFire Challenge A first heartbeat. First smile. First step. The First 1000 Days of life are the most critical in human development. This unique window immensely impacts the trajectory of health. As the overall approach to healthcare ...
Cyril Titeux
CYRIL TITEUX COMPANY GROUP CHAIRMAN ASIA PACIFIC JOHNSON & JOHNSON INNOVATIVE MEDICINE Cyril Titeux is Company Group Chairman, Johnson & Johnson Innovative Medicine Asia Pacific, and a member of the Innovative Medicine Group Operating Committee ...
Our Leadership
Meet Our Leadership Team Janssen aims to change the way diseases are treated, and aggressively pursues new pathways, investigating new technologies and treatment modalities in Oncology, Immunology, Neuroscience, Infectious Diseases & Vaccines, ...
J&J and Boston University Team Up to Tackle Lung Cancer
J&J and Boston University Team Up to Tackle Lung Cancer Lung cancer is the leading cause of cancer mortality across the globe, claiming more lives than colon, breast and prostate cancers—combined. At the 2018 BIO International Convention, Johnson & ...
Tammy Guld, M.S.
Tammy Guld, M.S. GLOBAL LEAD, JCI Tammy is the Global Lead of Janssen Clinical Innovation, with more than 20 years of experience in strategic and operational delivery across clinical development, regulatory affairs, and healthcare innovation. Based in New ...
Geothermal Energy: Ecological Innovation
Geothermal Energy: Ecological Innovation Oct 19, 2022 ...